Zdrowie i gospodarka · 07/06/2017

FDA Hosts Public Workshop on Developing Rabies Monoclonal Antibody Products for Post-Exposure Prophylaxis

The US Food and Drug Administration is hosting a public workshop to gather input from healthcare providers, government agencies, academics, and industry experts on the development of rabies monoclonal antibody products to be used in conjunction with licensed rabies vaccines as part of post-exposure prophylaxis (PEP) regimens.